Literature DB >> 4448070

Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives.

R R Tremblay, J Y Dube.   

Abstract

Entities:  

Keywords:  Androgens; Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Endocrine System; Ethinyl Estradiol; Examinations And Diagnoses; Family Planning; Hormones; Laboratory Examinations And Diagnoses; Laboratory Procedures; Mestranol; Norethindrone; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Research Methodology; Testosterone--analysis

Mesh：

Substances：

Year:  1974        PMID： 4448070     DOI： 10.1016/0010-7824(74)90099-7

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  34 in total

1.  Changed levels of endogenous sex steroids in women on oral contraceptives.

Authors:  J M Kjeld; C M Puah; G F Joplin
Journal:  Br Med J       Date:  1976-12-04

2.  Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens.

Authors:  J Bancroft; B B Sherwin; G M Alexander; D W Davidson; A Walker
Journal:  Arch Sex Behav       Date:  1991-04

3.  Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women.

Authors:  Sundeep Khosla; B Lawrence Riggs; Richard A Robb; Jon J Camp; Sara J Achenbach; Ann L Oberg; Peggy A Rouleau; L Joseph Melton
Journal:  J Clin Endocrinol Metab       Date:  2005-07-05       Impact factor: 5.958

4.  The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.

Authors:  J A Marcondes; S L Minanni; W W Luthold; A C Lerário; M Nery; B B Mendonça; B L Wajchenberg; M A Kirschner
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

5.  A rapid procedure for measurement of the free testosterone fraction in human plasma using the centria radioimmunoassay centrifugal analyzer.

Authors:  S Schwarz; J Boyd
Journal:  Arch Gynecol       Date:  1981

6.  Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Authors:  C J Malkin; P J Pugh; P D Morris; K E Kerry; R D Jones; T H Jones; K S Channer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Expression of type-2 histo-blood group carbohydrate antigens (Le(x), Le(y), and H) in normal and malignant human endometrium.

Authors:  V Ravn; U Mandel; B Svenstrup; E Dabelsteen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.

Authors:  Erin Golden; Ana Emiliano; Stuart Maudsley; B Gwen Windham; Olga D Carlson; Josephine M Egan; Ira Driscoll; Luigi Ferrucci; Bronwen Martin; Mark P Mattson
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women.

Authors:  Gail A Laughlin; Vivian Goodell; Elizabeth Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2009-11-24       Impact factor: 5.958

10.  Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men.

Authors:  K R Segal; A Dunaif; B Gutin; J Albu; A Nyman; F X Pi-Sunyer
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.